CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Increasing volume of clinical trial studies
4.1.2. Increasing R&D investments and government support
4.1.3. Growing expansion activities by contract research organisations
4.1.4. Rising incidences of various diseases
4.2. Market Restraints & Challenges
4.2.1. Longer approval times for clinical trials
4.3. Market Opportunities
4.3.1. Increasing number of patient expirations and the development of generic drugs
CHAPTER 5 GLOBAL CLINICAL TRIAL SUPPLIES MARKET – BY PRODUCT &
SERVICE
5.1. Manufacturing
5.2. Storage & Distribution
5.2.1. Cold Chain Based
5.2.2. Non-Cold Chain Based
5.3. Supply Chain Management
CHAPTER 6 GLOBAL CLINICAL TRIAL SUPPLIES MARKET – BY PHASE
6.1. Phase I
6.2. Phase II
6.3. Phase III
6.4. Others
CHAPTER 7 GLOBAL CLINICAL TRIAL SUPPLIES MARKET – BY
THERAPEUTIC AREA
7.1. Oncology
7.2. CNS (Central Nervous System)
7.3. Cardiovascular
7.4. Infectious Disease
7.5. Metabolic Disorders
7.6. Others
CHAPTER 8 GLOBAL CLINICAL TRIAL SUPPLIES MARKET – BY END USER
8.1. Pharmaceuticals
8.2. Biologics
8.3. Medical Devices
8.4. Others
CHAPTER 9 GLOBAL CLINICAL TRIAL SUPPLIES MARKET - BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. APAC
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10 GLOBAL CLINICAL TRIAL SUPPLIES MARKET - COMPANY
PROFILES
10.1. Sharp Packaging Services
10.2. Thermo Fisher Scientific
10.3. Alamc Group LTD
10.4. Catalent Pharma Solutions, Inc.
10.5. KLIFO A/S
10.6. Biocair
10.7. PAREXEL International Corporation
10.8. Patheon, Inc.
10.9. PCI Services
10.10. Movianto GmbH
10.11. Clinigen Group PLC
10.12. Merck Serono
10.13. Chemerix
10.14. Rubicon Research Pvt. Ltd.,
10.15. Durbin PLC
CHAPTER 11 GLOBAL CLINICAL TRIAL SUPPLIES MARKET - COMPETITIVE
LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12 MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13 APPENDIX
13.1. List of Tables
13.2. List of Figures
